October 2026
- Conducting Research with Involuntarily Hospitalized Patients — Ethical, Legal, and Regulatory Considerations
- Ianalumab for the Treatment of Patients with Sjögren’s Disease
- Tuberculous Empyema Resulting in Pseudochylothorax
- Role for Factor XIa Inhibitors after an Acute Coronary Syndrome Event
- Infective Endocarditis — When Is Enough Enough?
- Examining the Use of Race in Clinical Algorithms
- Case 30-2026: A 52-Year-Old Man with Vision Loss in the Left Eye
- Mavacamten and Obstructive Hypertrophic Cardiomyopathy in Teens
- In Vivo Aquaporin-1 Circular RNA Therapy for Radiation-Induced Xerostomia
- Pulsed Field Ablation for Persistent Atrial Fibrillation
- Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
- IVUS-Guided PCI in Left Main Coronary Disease
- Helicobacter pylori Infection — Advances, Challenges, and the Road Ahead
- Ianalumab in Sjögren’s Disease — A First Step
- Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea
- Spinal Tuberculosis
- Community Engagement Requirements in Medicaid — Law as a Determinant of Health
- Why Shared-Savings ACOs Have Failed to Deliver for Primary Care
- What I See before Anyone Speaks
- Continuous Glucose Monitoring in Non–Insulin-Treated Type 2 Diabetes
- Continuous or Intermittent Renal-Replacement Therapy — What Is the Question?
- Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury
- Clinical Trial Prediction Markets — Information, at What Cost?
- Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes
- Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
- Short or Long Antibiotic Regimens in Orthopedics
- Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
- Reengineering Coagulation with a Bispecific Antibody
- Tozorakimab to Prevent COPD Exacerbations
- Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
- Immediate Ambulatory Electrocardiographic Monitoring in Syncope
- Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation
- Pulmonary Denervation for Heart Failure–Related Pulmonary Hypertension
- Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients
- The Emerging Role of Treatment Policy Implementation Trials in Acute Coronary Syndrome
- Prasugrel versus Ticagrelor in Acute Coronary Syndromes
- Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI
- Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
- Prevalence of Silent Atherosclerosis across Adult Life
- Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain
- Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
- Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis
- Eplontersen for Transthyretin Amyloid Cardiomyopathy
- Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty
- Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609.